The primary objective of this book is to provide a comprehensive examination of epigenetic, proteomic, and metabolomic mechanisms and their roles in countering chronic inflammation, with a particular emphasis on cellular aspects.

A significant focus will also be placed on the analysis of neurological and age-related biomarkers. Moreover, the book explores plant-based substances, which exhibit potential in slowing down the progression of various conditions.

These substances are characterized by their simple and modifiable molecular structures, lack of patents, ease of acquisition, and, most importantly, low cost.